The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Cancer Screening and Early Detection in the 21st Century
Open accessAbstract
Objective To review the trends in and principles of cancer screening and early detection. Data Sources Journal articles, United States Preventive Services Task Force (U SPSTF) publications, professional organization position statements, evidence-based summaries Conclusion Cancer screening has contributed to decreasing the morbidity and mortality of cancer. Efforts to improve the selection of candidates for cancer screening, to understand the biological basis of carcinogenesis, and the development of new technologies for cancer screening will allow for improvements in the cancer screening over time. Implications for Nursing Practice Nurses are well-positioned to lead the implementation of cancer screening recommendations in the 21st Century through their practice, research, educational efforts and advocacy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Richards, S., Aziz, N., Bale, S., Bick, D., Das, S., Gastier-Foster, J., Grody, W. W., Hegde, M., Lyon, E., Spector, E., et al. (2015) · Genetics in Medicine · doi:10.1038/gim.2015.30 · Cited by 32,594
Genetic Alterations during Colorectal-Tumor Development
Vogelstein, B., Fearon, E. R., Hamilton, S. R., Kern, S. E., Preisinger, A. C., Leppert, M., Smits, A. M. M., & Bos, J. L. (1988) · New England Journal of Medicine · doi:10.1056/nejm198809013190901 · Cited by 6,728
Gail, M. H., Brinton, L. A., Byar, D. P., Corle, D. K., Green, S. B., Schairer, C., & Mulvihill, J. J. (1989) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/81.24.1879 · Cited by 3,334
Rubin, M., & Stephen, C. D. (1993) · Cited by 3,149
Soft-Tissue Sarcomas, Breast Cancer, and Other Neoplasms: A Familial Syndrome?
LI, F. P., & FRAUMENI, J. F. (1969) · Annals of Internal Medicine · doi:10.7326/0003-4819-71-4-747 · Cited by 1,509
Buys, S. S. (2011) · JAMA · doi:10.1001/jama.2011.766 · Cited by 1,323
Jacobs, I. J., Menon, U., Ryan, A., Gentry-Maharaj, A., Burnell, M., Kalsi, J. K., Amso, N. N., Apostolidou, S., Benjamin, E., Cruickshank, D., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(15)01224-6 · Cited by 1,048 · cited 2×
“Despite its promise, this co-testing strategy has not resulted in overall reduction in mortality from ovarian cancer.(26,33) The UK trial tested a proprietary algorithm named ROCA that adjusted the biomarker level cut-off for normal results based on women’s clinical characteristics and the TV ultrasound result.”
BackgroundMethod[Principles and practice of mass screening for disease].
Wilson, J. M., & Jungner, Y. G. (1968) · PubMed · Cited by 1,009
Prognostic Indices for Older Adults: A Systematic Review
Yourman, L. C., Lee, S. J., Schonberg, M. A., Widera, E. W., & Smith, A. K. (2012) · JAMA · doi:10.1001/jama.2011.1966 · Cited by 736 · cited 1×
“Future research will address the utility of these tools across all cancer screening recommendations to identify those who will benefit most from screening and those most likely to be harmed.(35)”
MethodPrecision Public Health for the Era of Precision Medicine
Khoury, M. J., Iademarco, M. F., & Riley, W. T. (2016) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2015.08.031 · Cited by 569
Amendola, L. M., Jarvik, G. P., Leo, M. C., McLaughlin, H. M., Akkari, Y., Amaral, M. D., Berg, J. S., Biswas, S., Bowling, K. M., Conlin, L. K., et al. (2016) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2016.03.024 · Cited by 551
MUC16 (CA125): tumor biomarker to cancer therapy, a work in progress
Felder, M., Kapur, A., Gonzalez-Bosquet, J., Horibata, S., Heintz, J., Albrecht, R., Fass, L., Kaur, J., Hu, K., Shojaei, H., et al. (2014) · Molecular Cancer · doi:10.1186/1476-4598-13-129 · Cited by 524
Addressing overdiagnosis and overtreatment in cancer: a prescription for change
Esserman, L. J., Thompson, I. M., Reid, B., Nelson, P., Ransohoff, D. F., Welch, H. G., Hwang, S., Berry, D. A., Kinzler, K. W., Black, W. C., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70598-9 · Cited by 501
Origin and molecular pathogenesis of ovarian high-grade serous carcinoma
Kurman, R. J. (2013) · Annals of Oncology · doi:10.1093/annonc/mdt463 · Cited by 336
Cramer, D. W., Bast, R. C., Berg, C. D., Diamandis, E. P., Godwin, A. K., Hartge, P., Lokshin, A. E., Lu, K. H., McIntosh, M. W., Mor, G., et al. (2011) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-10-0195 · Cited by 300
Population-Based Screening for BRCA1 and BRCA2: 2014 Lasker Award
King, M.-C., Levy-Lahad, E., & Lahad, A. (2014) · JAMA · doi:10.1001/jama.2014.12483 · Cited by 275
Clinical Use of Cancer Biomarkers in Epithelial Ovarian Cancer
Sölétormos, G., Duffy, M. J., Hassan, S. O. A., Verheijen, R. H. M., Tholander, B., Bast, R. C., Gaarenstroom, K. N., Sturgeon, C. M., Bonfrer, J. M., Petersen, P. H., et al. (2016) · International Journal of Gynecological Cancer · doi:10.1097/igc.0000000000000586 · Cited by 255
Fleshner, K., Carlsson, S. V., & Roobol, M. J. (2017) · Nature Reviews Urology · doi:10.1038/nrurol.2016.251 · Cited by 219
(2016) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000001708 · Cited by 175
Population-based screening for cancer: hope and hype
Shieh, Y., Eklund, M., Sawaya, G. F., Black, W. C., Kramer, B. S., & Esserman, L. J. (2016) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.50 · Cited by 166
Breast cancer risk prediction using a clinical risk model and polygenic risk score
Shieh, Y., Hu, D., Ma, L., Huntsman, S., Gard, C. C., Leung, J. W. T., Tice, J. A., Vachon, C. M., Cummings, S. R., Kerlikowske, K., et al. (2016) · Breast Cancer Research and Treatment · doi:10.1007/s10549-016-3953-2 · Cited by 160
Qaseem, A., Humphrey, L. L., Harris, R., Starkey, M., & Denberg, T. D. (2014) · Annals of Internal Medicine · doi:10.7326/m14-0701 · Cited by 137
(2011) · Obstetrics and Gynecology · doi:10.1097/aog.0b013e31821477db · Cited by 134
Byers, T., Wender, R. C., Jemal, A., Baskies, A. M., Ward, E. E., & Brawley, O. W. (2016) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21348 · Cited by 112
Li-Fraumeni syndrome: report of a clinical research workshop and creation of a research consortium
Mai, P. L., Malkin, D. M., Garber, J. E., Schiffman, J. D., Weitzel, J. N., Strong, L. C., Wyss, O., Locke, L., Means, V., Achatz, M. I., et al. (2012) · Cancer Genetics · doi:10.1016/j.cancergen.2012.06.008 · Cited by 105
Limitations of the pelvic examination for evaluation of the female pelvic organs
Padilla, L., Radosevich, D. M., & Milad, M. P. (2004) · International Journal of Gynecology & Obstetrics · doi:10.1016/j.ijgo.2004.09.015 · Cited by 98
Committee Opinion No. 534: Well-Woman Visit
(2012) · Obstetrics and Gynecology · doi:10.1097/aog.0b013e3182680517 · Cited by 74
Dayyani, F., Uhlig, S., Colson, B., Simon, K., Rolny, V., Morgenstern, D., & Schlumbrecht, M. (2016) · International Journal of Gynecologic Cancer · doi:10.1097/igc.0000000000000804 · Cited by 68
Doroudi, M., Kramer, B. S., & Pinsky, P. F. (2016) · Journal of Medical Screening · doi:10.1177/0969141316680381 · Cited by 19
Cancer Screening: The Journey from Epidemiology to Policy
Deppen, S. A., Aldrich, M. C., Hartge, P. A., Berg, C. D., Colditz, G. A., Petitti, D. B., & Hiatt, R. A. (2012) · Annals of Epidemiology · doi:10.1016/j.annepidem.2012.03.004 · Cited by 16
Cited by
Colorectal cancer statistics, 2023
Siegel, R. L., Wagle, N. S., Cercek, A., Smith, R. A., & Jemal, A. (2023) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21772 · Cited by 3,733
Management of Rheumatoid Arthritis: An Overview
Radu, A.-F., & Bungau, S. G. (2021) · Cells · doi:10.3390/cells10112857 · Cited by 1,089
Chunarkar-Patil, P., Kaleem, M., Mishra, R., Ray, S., Ahmad, A., Verma, D., Bhayye, S., Dubey, R., Singh, H., & Kumar, S. (2024) · Biomedicines · doi:10.3390/biomedicines12010201 · Cited by 390
Biosensing based on field-effect transistors (FET): Recent progress and challenges
Sadighbayan, D., Hasanzadeh, M., & Ghafar-Zadeh, E. (2020) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2020.116067 · Cited by 305
A socio-ecological framework for cancer prevention in low and middle-income countries
Akinyemiju, T., Ogunsina, K., Gupta, A., Liu, I., Braithwaite, D., & Hiatt, R. A. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.884678 · Cited by 48
Metadata
- Authors
- Loud, J. T., & Murphy, J.
- Venue
- Seminars in Oncology Nursing
- Publisher
- Elsevier BV
- Published
- 2017-05
- Volume
- 33
- Issue
- 2
- Pages
- 121-128
- ISSN
- 0749-2081 (ISSN-L)
- OpenAlex
- W2597886184
- Cited by
- 289
- References
- 30
- FWCI
- 3.23
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.